These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6431438)

  • 21. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.
    Peerlinck K; Arnout J; Di Giambattista M; Gilles JG; Laub R; Jacquemin M; Saint-Remy JM; Vermylen J
    Thromb Haemost; 1997 Jan; 77(1):80-6. PubMed ID: 9031454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired hemophilia and its treatment.
    Sultan Y
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of factor VIII inhibitor in three non-hemophiliac patients].
    Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
    Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy.
    Moccia F; Tognoni E; Boccaccio P
    Ann Ital Med Int; 2000; 15(2):172-6. PubMed ID: 10920509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of the bleeding inhibitor patient.
    Astermark J
    Semin Thromb Hemost; 2003 Feb; 29(1):77-86. PubMed ID: 12640569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antifactor VIII antibody in Rosai-Dorfman disease].
    Lorenzini JL; Allain JP; Chalopin JM; Rifle G; Devilliers E; Carli PM; Cortet P; Bonhomme J
    Nouv Rev Fr Hematol (1978); 1983; 25(1):23-6. PubMed ID: 6403924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital.
    Angchaisuksiri P; Atichartakarn V; Pathepchotiwong K; Jootar S; Ungkanont A; Chuncharunee S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():152-8. PubMed ID: 7886560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of inhibitors to factor VIII and IX.
    Roberts HR; Cromartie R
    Prog Clin Biol Res; 1984; 150():1-18. PubMed ID: 6431420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoantibodies against coagulation factor VIII].
    Friis-Hansen LJ; Andersen NS; Scheibel E
    Ugeskr Laeger; 1998 Oct; 160(42):6061-5. PubMed ID: 9800508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Remission of a non-haemophilic patient with acquired factor VIII inhibitor treated with infusion of factor VIII and corticosteroid].
    Honda J; Egami K; Osabe S; Natori H; Nakamura E; Tanaka K; Naitou K; Kaji M
    Rinsho Ketsueki; 1989 Apr; 30(4):520-4. PubMed ID: 2504978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Spontaneous ecchymosis disclosing acquired factor VIII inhibitor].
    Bayrou O; Deschamps A; Laurian C; Braunstein C; Leynadier F
    Ann Dermatol Venereol; 1993; 120(8):546-8. PubMed ID: 8304713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.
    Green D; Rademaker AW; Briët E
    Thromb Haemost; 1993 Nov; 70(5):753-7. PubMed ID: 8128430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.